Rajarshi Banerjee practices in Oxford, United Kingdom. Banerjee is highly rated in 13 conditions, according to our data. Their top areas of expertise are Non-Alcoholic Fatty Liver Disease, Long Haul COVID, Autoimmune Hepatitis, and Nonalcoholic Steatohepatitis (NASH).
Their clinical research consists of co-authoring 128 peer reviewed articles and participating in 7 clinical trials in the past 15 years.
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.